Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Cancer Face”

135 trials

Showing 20 of 135 results

Not applicableStudy completedNCT07384299
What this trial is testing

Impact of Skin Type on Wonud Healing and Scarring Following Facial Skin Surgery

Who this might be right for
NevusSeborrheic Keratosis (SK)Cyst+2 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 173
Not applicableUnknownNCT04485442
What this trial is testing

Patient Reported Outcome Measures After Treatment of Skin Cancers on the Face

Who this might be right for
Skin Cancer
University Hospital, Basel, Switzerland 100
Early research (Phase 1)Study completedNCT01836367
What this trial is testing

Ingenol Mebutate 0.015% Gel in the Treatment of Actinic Keratoses (AK) on the Face and Scalp

Who this might be right for
Actinic Keratosis
Icahn School of Medicine at Mount Sinai 20
Post-approval studies (Phase 4)Study completedNCT02866695
What this trial is testing

Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of AK on the Face in Solid Organ Transplant Recipients

Who this might be right for
Actinic Keratosis
University of California, San Francisco 20
Not applicableStudy completedNCT02674048
What this trial is testing

Metvix Daylight PDT in Actinic Keratosis

Who this might be right for
Actinic Keratosis
Galderma R&D 406
Post-approval studies (Phase 4)Study completedNCT02716714
What this trial is testing

Clinical Trial of Ingenol Mebutate Gel 0.015% & 0.05% in Actinic Keratosis

Who this might be right for
Actinic Keratosis
Korea University 77
Large-scale testing (Phase 3)Study completedNCT01600014
What this trial is testing

Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and Scalp

Who this might be right for
Actinic Keratosis
LEO Pharma 463
Large-scale testing (Phase 3)Study completedNCT02611804
What this trial is testing

A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald Scalp

Who this might be right for
Actinic Keratosis
Teva Pharmaceuticals USA 492
Large-scale testing (Phase 3)Study completedNCT00915551
What this trial is testing

A Multi-Center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)

Who this might be right for
Actinic Keratosis
Peplin 278
Not applicableLooking for participantsNCT07257094
What this trial is testing

Nasal Reconstruction FACE-Q : French Validation of the Nasal Reconstruction FACE-Q Questionnaire for Reconstruction/Rehabilitation Following Nasal Skin Cancer

Who this might be right for
Carcinoma
Hôpital NOVO 346
Large-scale testing (Phase 3)Study completedNCT02549339
What this trial is testing

Efficacy and Safety of LEO 43204 in the Field Treatment of Actinic Keratosis on Face or Chest including12-month Follow-up

Who this might be right for
Actinic Keratosis
LEO Pharma 383
Post-approval studies (Phase 4)Study completedNCT00204542
What this trial is testing

Comparison of the Efficacy and Tolerability of Solaraze for 3 Versus 6 Months in Patients With Mild to Moderate Actinic Keratosis Located on the Face and Head

Who this might be right for
Photosensitivity Disorders
University Hospital Tuebingen 418
Not applicableUnknownNCT05602337
What this trial is testing

A Prospective Multicenter Sample Collection Study Using Non-invasive Methods to Investigate Mutation Burden in Non-lesional Facial Skin of Patients With a Hx of Skin Cancer

Who this might be right for
Melanoma and Other Malignant Neoplasms of Skin
DermTech 180
Not applicableStudy completedNCT06837701
What this trial is testing

The True Face of the Pyramid; Physical Activity Level and Cardiovascular Risk in Patients With Breast Cancer

Who this might be right for
Breast CancerCardiovascular DiseasePhysical Activity
Hacettepe University 70
Post-approval studies (Phase 4)Study completedNCT03511326
What this trial is testing

PRO With Luxerm® in the Field Treatment of Thin and Non-hyperkeratotic Non-pigmented AK

Who this might be right for
Actinic Keratoses
Galderma R&D 50
Large-scale testing (Phase 3)Study completedNCT01720407
What this trial is testing

Relevance of Imiquimod as Neo-adjuvant Treatment to Reduce Excision Size and the Risk of Intralesional Excision in Lentigo Malignant of the Face

Who this might be right for
Lentigo Maligna Melanoma (Head or Neck)
Nantes University Hospital 259
Post-approval studies (Phase 4)Study completedNCT02736760
What this trial is testing

Daylight-PDT With MAL for AK and Photodamaged Skin

Who this might be right for
Actinic KeratosesPhotodamaged Skin
University Hospital Regensburg 58
Post-approval studies (Phase 4)Study completedNCT01453179
What this trial is testing

Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2)

Who this might be right for
Actinic Keratosis
MEDA Pharma GmbH & Co. KG 221
Not applicableWithdrawnNCT03382704
What this trial is testing

Vellus Hair Loss as a Marker for Peri-ocular Malignancy

Who this might be right for
Skin Cancer Face
NHS Lothian
Large-scale testing (Phase 3)Study completedNCT00569582
What this trial is testing

The Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome

Who this might be right for
Cushing's Syndrome
Corcept Therapeutics 50
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation